B.A.B.N. Herbal Medicine Innovations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.00 Cr
- Revenue Growth 126.08%
- Profit Growth -80.36%
- Ebitda -371.91%
- Net Worth 174.70%
- Total Assets 50.81%
About B.A.B.N. Herbal Medicine Innovations
B.A.B.N. Herbal Medicine Innovations Private Limited (BHMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 April 2016 (Eight years and nine months 19 days old ). Its registered office is in Ahmed Nagar, Maharashtra, India.
The Corporate was formerly known as B.A.B.N. Nirmit Pachak Arogya Vardhini Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Laxman Shinde and Sachin Changedia serve as directors at the Company.
Company Details
-
Location
Ahmed Nagar, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999PN2016PTC164059
-
Company No.
164059
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Apr 2016
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at B.A.B.N. Herbal Medicine Innovations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laxman Shinde
|
Director | 21-Apr-2016 | Current |
|
Sachin Changedia
|
Director | 21-Apr-2016 | Current |
Financial Performance of B.A.B.N. Herbal Medicine Innovations.
B.A.B.N. Herbal Medicine Innovations Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 126.08% increase. The company also saw a substantial fall in profitability, with a 80.36% decrease in profit. The company's net worth Soared by an impressive increase of 174.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B.A.B.N. Herbal Medicine Innovations?
In 2018, B.A.B.N. Herbal Medicine Innovations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jan 2020 | Others | ₹1.00 Cr | Open |
How Many Employees Work at B.A.B.N. Herbal Medicine Innovations?
Unlock and access historical data on people associated with B.A.B.N. Herbal Medicine Innovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B.A.B.N. Herbal Medicine Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B.A.B.N. Herbal Medicine Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.